| pro_cas |
pro_molName |
pro_formula |
|
133565-47-6
|
FMOC-L-METHIONINOL |
C20 H23 N O3 S |
|
1490-44-4
|
3-CHLORO-6-PHENOXYPYRIDAZINE |
C10 H7 Cl N2 O |
|
16872-10-9
|
1-METHYL-O-CARBORANE |
C3 H14 B10 |
|
19496-84-5
|
1-BROMOMETHYL-O-CARBORANE |
C3 H13 B10 Br |
|
18664-32-9
|
1,3-DIMETHOXYACETONE |
C5 H10 O3 |
|
14064-13-2
|
1-HYDROXYMETHYL-1-METHYLCYCLOHEXANE |
C8 H16 O |
|
14399-14-5
|
CHLORAMPHENICOL CINNAMATE |
C17 H18 Cl2 N2 O11 |
|
1328-71-8
|
CUPRIC UNDECYLENATE |
C22 H42 Cu O4 |
|
18251-84-8
|
ZINC SODIUM FLUORIDE |
F . F2 Zn . Na |
|
1600-76-6
|
5ALPHA-ANDROSTAN-3ALPHA,17BETA-DIOL 3-ACETATE |
C21 H34 O3 |
|
119039-60-0
|
5ALPHA-ANDROSTAN-3ALPHA,17BETA-DIOL 17-SULPHATE SODIUM SALT |
C19 H31 O5 S . Na |
|
1225-01-0
;65556-19-6
|
19-NORANDROSTERONE |
C18 H28 O2 |
|
15087-01-1
|
ESTRONE BETA-D-GLUCURONIDE SODIUM SALT |
C24 H29 O8 . Na |
|
1852-36-4
|
HYDROCORTISONE 21-(SODIUM SULPHATE) |
C21 H29 O8 S . Na |
|
127132-38-1
|
BOC-L-TYR(ALL)-OH |
C17 H23 N O5 |
|
142348-55-8
|
N-BOC-(4-DIETHYLPHOSPHONOMETHYL)-L-PHENYLALANINE |
C19 H30 N O7 P |
|
129288-36-4
|
FMOC-ASN(TRT)-NCA |
C39 H30 N2 O6 |
|
150009-58-8
|
FMOC-D-ASP(OBZL)-OH |
C26 H23 N O6 |
|
129288-38-6
|
FMOC-GLN(TRT)-NCA |
C40 H32 N2 O6 |
|
176039-39-7
|
(RS)-2-(BOC-AMINO)-2-(FMOC-AMINO)-ACETIC ACID |
C22 H24 N2 O6 |
|
146982-30-1
|
FMOC-TYR(ALL)-OH |
C27 H25 N O5 |
|
135944-08-0
|
N-FMOC-D,L-2-AMINOTETRALIN-2-CARBOXYLIC ACID |
C26 H23 N O4 |
|
129605-53-4
|
(2S)-2-((5S)-1-[(9H-FLUOREN-9-YL-METHOXY)CARBONYL]-6-OXO-1,7-DIAZASPIRO[4.4]NON-7-YL)-4-METHYLPENTANOIC ACID |
C28 H32 N2 O5 |
|
149299-77-4
|
H-THR-SER-THR-GLU-PRO-GLN-TYR(PO3H2)-GLN-PRO-GLY-GLU-ASN-LEU-OH |
C62 H95 N16 O28 P |
|
143868-20-6
|
GALANIN (1-13)-SPANTIDE I |
C138 H199 N35 O30 |
|
148473-36-3
|
JMV 390-1 |
C23 H35 N3 O6 |
|
141368-69-6
|
FLUM1 A2 (58-66) |
C49 H75 N9 O11 |
|
159439-02-8
|
AC-TYR(PO3H2)-GLU-GLU-ILE-GLU |
C32 H46 N5 O17 P |
|
159396-61-9
|
Z-GLY-NCA |
C11 H9 N O5 |
|
131417-68-0
|
(+/-)-2-AMINO-3-[3-(CARBOXYMETHOXY)-5-METHYL-ISOXAZOL-4-YL]PROPIONIC ACID |
C9 H12 N2 O6 |
|
126761-43-1
|
10-TRANS-HEPTADECENOIC ACID |
C17 H32 O2 |
|
102068-15-5
|
GLY-MET-ALA-SER-LYS-ALA-GLY-ALA-ILE-ALA-GLY-LYS-ILE-ALA-LYS-VAL-ALA-LEU-LYS-ALA-LEU-NH2 |
C88 H162 N26 O22 S |
|
135261-87-9
|
NLE-ANTIFLAMMIN-2 |
C44 H72 N12 O17 |
|
152918-32-6
|
N6-BENZYL-5'-ETHYLCARBOXAMIDOADENOSINE |
C20 H24 N6 O4 |
|
14008-79-8
|
3-CPMT |
C21 H24 Cl N O . Cl H |
|
163401-68-1
|
2-CHLORO-4-METHYLTHIOBUTANOIC ACID |
C5 H9 Cl O2 S |
|
10275-21-5
|
N,N-DIMETHYL-1-PHENYL-2-ETHANAMINE HYDROCHLORIDE |
C10 H15 N . Cl H |
|
138449-07-7
|
FK 888 |
C36 H36 N4 O4 |
|
126766-32-3
|
4-([3,4-DICHLOROPHENYL]ACETYL)-3-(1-PYRROLIDINYLMETHYL)-1-PIPERAZINECARBOXYLIC ACID METHYL ESTER FUMARATE |
C19 H25 Cl2 N3 O3 . C4 H4 O4 |
|
114562-59-3
|
(+/-)-N-HYDROXY MDA |
C10 H13 N O3 |
|
129944-99-6
|
M-HYDROXYBENZOYLECGONINE |
C16 H19 N O5 |
|
82730-72-1
;1021878-34-1
|
R-(+)-2-DIPROPYLAMINO-7-HYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE HYDROBROMIDE |
C16 H25 N O . Br H |
|
128767-12-4
|
MBDB HYDROCHLORIDE |
C12 H17 N O2 . Cl H |
|
157798-12-4
|
5-NONYLOXYTRYPTAMINE OXALATE |
C19 H30 N2 O . C2 H2 O4 |
|
136623-01-3
|
NS 102 |
C12 H11 N3 O4 |
|
142246-63-7
|
5'-O-(4,4'-DIMETHOXYTRITYL)-5-FLUORODEOXYURIDINE-3'-(2-CYANOETHYL-N,N-DIISOPROPYL)PHOSPHORAMIDITE |
C39 H46 F N4 O8 P |
|
103285-22-9
|
5'-O-(4,4'-DIMETHOXYTRITYL)-2'-O-METHYLURIDINE |
C31 H32 N2 O8 |
|
1701-57-1
|
2,3,4,5-TETRAHYDRO-1H-BENZO[B]AZEPINE |
C10 H13 N |
|
123799-93-9
|
4-METHYLPYRAZOLE SULFATE |
C4 H6 N2 . H2 O4 S |
|
105907-08-2
|
6-CHLORO-2,4,8-TRIMETHYLQUINOLINE |
C12 H12 Cl N |
|
185437-33-6
|
6,7-DIMETHYL-4-HYDROXYQUINOLINE |
C11 H11 N O |
|
178984-37-7
|
7,8-DIMETHYL-4-QUINOLINOL |
C11 H11 N O |
|
137110-39-5
|
2-AMINO-3,6-DIMETHYLQUINOLINE |
C11 H12 N2 |
|
137110-41-9
|
2-AMINO-3,8-DIMETHYLQUINOLINE |
C11 H12 N2 |
|
137110-42-0
|
2-AMINO-6-CHLORO-3-METHYLQUINOLINE |
C10 H9 Cl N2 |
|
10482-65-2
|
CINNAMYL VALERATE |
C14 H18 O2 |
|
18709-01-8
|
2-OXOCYCLOHEXANECARBOXYLIC ACID |
C7 H10 O3 |
|
168916-68-5
|
(HIS32,LEU34)-NEUROPEPTIDE Y (32-36) |
C33 H54 N14 O6 |
|
161650-01-7
;82785-45-3
|
(PRO30,TYR32,LEU34)-NEUROPEPTIDE Y (28-36) |
C57 H91 N17 O12 |
|
156707-43-6
|
H-CYS-4-ABZ-MET-OH |
C15 H21 N3 O4 S2 |
|
158022-12-9
|
FTASE INHIBITOR III |
C26 H36 N4 O5 S2 |
|
172516-80-2
|
FIBRONECTIN RECEPTOR PEPTIDE (124-131) |
C49 H72 N8 O15 S |
|
175799-54-9
|
H-TYR-SER-PHE-VAL-HIS-HIS-GLY-PHE-PHE-ASN-PHE-ARG-VAL-SER-TRP-ARG-GLU-MET-LEU-ALA-OH |
C121 H164 N32 O27 S |
|
172617-89-9
|
AC-NLE-GLN-HIS-D-PHE-ARG-D-TRP-GLY-NH2 |
C47 H65 N15 O9 |
|
153247-40-6
|
BETA-AMYLOID (16-20) |
C35 H52 N6 O6 |
|
16635-54-4
|
CIS-2-HEXENAL |
C6 H10 O |
|
10519-37-6
|
HEXYL ISO-EUGENOL |
C16 H24 O2 |
|
172997-92-1
|
((CYS31,NVA34)-NEUROPEPTIDE Y (27-36))2 |
C116 H186 N36 O28 S2 |
|
189064-08-2
|
[ALA92]-P16 (84-103) |
C93 H155 N31 O26 |
|
125791-92-6
|
H-ALA-PRO-AFC |
C18 H18 F3 N3 O4 |
|
16059-16-8
|
HEXAKIS(1H,1H,5H-OCTAFLUOROPENTOXY)PHOSPHAZINE |
C30 H18 F48 N3 O6 P3 |
|
186043-52-7
|
HEXAKIS(1H,1H-PERFLUOROOCTYLOXY)PHOSPHAZENE |
C48 H12 F90 N3 O6 P3 |
|
111651-46-8
;1020714-78-6
|
AZIDO-O-BENZOYL LACTIC ACID |
C10 H9 N3 O4 |
|
189696-01-3
|
MCA-TYR-VAL-ALA-ASP-ALA-PRO-LYS(DNP)-OH |
C53 H64 N10 O19 |
|
189696-20-6
|
7-METHOXYCOUMARIN-4-ACETYL-ASP-GLU-VAL-ASP-ALA-PRO-(2,4-DINITROPHENYL)LYS |
C50 H62 N10 O22 |
|
168135-79-3
|
AC-ASP-TYR(2-MALONYL)-VAL-PRO-MET-LEU-NH2 |
C39 H57 N7 O13 S |
|
150113-99-8
|
DECANOYL-ARG-VAL-LYS-ARG-CHLOROMETHYLKETONE |
C34 H66 Cl N11 O5 |
|
103489-31-2
|
3-(4-AZIDOPHENYL)PROPIONIC ACID |
C9 H9 N3 O2 |
|
103489-33-4
|
4-(4-AZIDOPHENYL)BUTYRIC ACID |
C10 H11 N3 O2 |
|
137052-25-6
|
(BOC)2-15NH |
C10 H19 N O4 |
